Angiotensin II in the treatment of distributive shock: a systematic-review and meta-analysis.

Xourgia, Eleni; Exadaktylos, Aristomenis K; Chalkias, Athanasios; Ziaka, Mairi (2024). Angiotensin II in the treatment of distributive shock: a systematic-review and meta-analysis. Shock, 62(2), pp. 155-164. Shock Society 10.1097/SHK.0000000000002384

[img]
Preview
Text
angiotensin_ii_in_the_treatment_of_distributive.436.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (1MB) | Preview

BACKGROUND

While non-norepinephrine vasopressors are increasingly used as a rescue therapy in cases of norepinephrine-refractory shock, data on their efficacy are limited. This systematic review and meta-analysis aims to synthesize existing literature on the efficacy of Angiotensin II (ATII) in distributive shock.

METHODS

We pre-registered our meta-analysis with PROSPERO (CRD42023456136). We searched PubMed, Scopus, and gray literature for studies presenting outcomes on ATII use in distributive shock. The primary outcome of the meta-analysis was all-cause mortality. We used a random effects model to calculate pooled risk ratio (RR) and 95% confidence intervals (CI).

RESULTS

By incorporating data from 1555 patients included in 10 studies, we found that however all-cause mortality was similar among patients receiving ATII and controls (RR 1.02, 95% CI 0.89 to 1.16, p = 0.81), the reduction in norepinephrine or norepinephrine-equivalent dose at 3 h after treatment initiation was greater among patients receiving ATII (MD -0.06, 95% CI -0.11 to -0.02, p = 0.008), while there were no higher rates of adverse events reported among ATII patients.

CONCLUSIONS

While ATII did not reduce mortality among distributive shock patients, it allowed for significant adjunctive vasopressor reduction at 3 h without an increase in reported adverse events, deeming it a viable alternative for the increasingly adopted multimodal vasopressor for minimizing catecholamine exposure and its adverse events.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > University Emergency Center

UniBE Contributor:

Exadaktylos, Aristomenis, Ziaka, Mairi

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1540-0514

Publisher:

Shock Society

Language:

English

Submitter:

Pubmed Import

Date Deposited:

20 Jun 2024 12:13

Last Modified:

18 Jul 2024 00:15

Publisher DOI:

10.1097/SHK.0000000000002384

PubMed ID:

38888542

BORIS DOI:

10.48350/197960

URI:

https://boris.unibe.ch/id/eprint/197960

Actions (login required)

Edit item Edit item
Provide Feedback